Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$5.32M Sell
108,738
-212,270
-66% -$9.85M 0.24% 128
2017
Q1
$15.1M Buy
+321,008
New +$15.3M 0.74% 32
2016
Q3
Sell
-70,628
Closed -$2.51M 730
2016
Q2
$2.51M Buy
70,628
+37,757
+115% +$1.47M 0.14% 192
2016
Q1
$1.29M Buy
+32,871
New +$1.23M 0.09% 245
2015
Q2
Sell
-251,233
Closed -$11.3M 999
2015
Q1
$11.3M Buy
251,233
+222,841
+785% +$10M 0.69% 19
2014
Q4
$1.37M Buy
+28,392
New +$1.35M 0.11% 224
2014
Q1
Sell
-30,789
Closed -$1.48M 799
2013
Q4
$1.48M Buy
+30,789
New +$1.38M 0.19% 135

Other funds holding MET

Airain Ltd's MET Position: Q2 2017 in Review

Airain Ltd reduced its MetLife (MET) stake by 66% in Q2 2017, selling an estimated $9.85M and leaving 108,738 shares worth $5.32M. The position accounts for 0.24% of the portfolio, ranked #128.

Airain Ltd first reported a position in MET in Q4 2013 and has held it in 7 quarters since. The position peaked at $15.1M in Q1 2017. 1,029 funds tracked by Wall St. Rank hold MET as of Q2 2017.

  • Airain Ltd held 108,738 shares of MetLife worth $5.32M as of Q2 2017.
  • Airain Ltd sold 212,270 MetLife shares in Q2 2017, an estimated $9.85M.
  • MetLife made up 0.24% of Airain Ltd's portfolio in Q2 2017, its #128 holding.
  • Airain Ltd first reported a position in MetLife in Q4 2013 and has held it in 7 quarters since.
  • Airain Ltd's MetLife position peaked at $15.1M in Q1 2017.
  • 1,029 funds tracked by Wall St. Rank held MetLife as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.